Scott Osabuohien
Psychiatric/Mental Health · Draper, UTNPI 1376281477
Payments from drug & device makers
Across 117 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$340
- Johnson & Johnson$324
- Neurocrine Biosciences, Inc.$309
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$294
- Otsuka America Pharmaceutical, Inc.$201
- Teva Pharmaceuticals USA, Inc.$153
- plus $688 from 9 others
What the payments were for
- Food & beverage$2,308100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $340 |
| Johnson & Johnson | 17 | $324 |
| Neurocrine Biosciences, Inc. | 12 | $309 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 13 | $294 |
| Otsuka America Pharmaceutical, Inc. | 11 | $201 |
| Teva Pharmaceuticals USA, Inc. | 9 | $153 |
| Lundbeck LLC | 8 | $152 |
| Axsome Therapeutics, Inc. | 6 | $140 |
| Vanda Pharmaceuticals Inc. | 4 | $126 |
| Idorsia Pharmaceuticals US Inc | 5 | $89 |
| Alkermes, Inc. | 4 | $84 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Biogen | 1 | $17 |
| Corium, LLC | 1 | $15 |
How this compares
$2,308 in reported general payments places this provider in the 80th percentile of 393 psychiatric/mental health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 39 | $947 |
| Buspirone Hcl | 31 | $548 |
| Duloxetine Hcl | 54 | $501 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 13 | $478 |
| Lamotrigine | 33 | $429 |
| Bupropion XlBupropion Hcl | 23 | $373 |
| Olanzapine | 17 | $318 |
| Prazosin Hcl | 24 | $309 |
| Quetiapine Fumarate | 28 | $230 |
| Amitriptyline Hcl | 14 | $218 |
| Fluoxetine Hcl | 17 | $215 |
| Clonazepam | 26 | $202 |
| Escitalopram Oxalate | 26 | $188 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $104 |
| Mirtazapine | 12 | $88 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Draper
- Nathan KroegelDraper$3K
- Bret HafenLayton$381K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
- Debra HainRiverton$29K
- Kristin BarberSalt Lake City$28K
- Briana TerrySalt Lake City$14K
- Paige MarshallSaint George$13K
- Derick MoodySpringville$8K
- Sumer AndersonSandy$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.